IGM Biosciences, Inc.
IGMSDelisted Aug 14, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496323
IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding IGM Biosciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 79 | 1 | 79 | +1 |
| Shares | 22.3M | 300 | 22.3M | +57.9K (+0.3%) |
| Value | $207.6M | $3.00K | $186.3M | −$21.3M (−10.3%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held IGM Biosciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ExodusPoint Capital Management, LP | 453,898 | $3.79M | 0.05% |
| First Manhattan Co | 172,200 | $1.44M | 0.01% |
| Hudson Bay Capital Management LP | 124,260 | $1.04M | 0.01% |
| Pale Fire Capital SE | 12,601 | $105.2K | 0.01% |
| State of Wisconsin Investment Board | 11,728 | $97.9K | 0.00% |
| XTX Topco Ltd | 11,445 | $95.6K | 0.02% |
| DekaBank Deutsche Girozentrale | 6,303 | $50.0K | 0.00% |
| Quantbot Technologies LP | 1,800 | $15.0K | 0.00% |
| Qube Research & Technologies Ltd | 936 | $7.82K | 0.00% |
| Cutler Group LP | 400 | $3.00K | 0.00% |
| Group One Trading, L.P. | 200 | $1.67K | 0.00% |
| Lindbrook Capital, LLC | 150 | $1.25K | 0.00% |
| NBC Securities, Inc. | 150 | $1.00K | 0.00% |
| Russell Investments Group, Ltd. | 96 | $802 | 0.00% |
| Nisa Investment Advisors, LLC | 53 | $443 | 0.00% |
Sold out (14)
Institutions that held IGM Biosciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Walleye Capital LLC | 69,417 | $640.7K |
| Susquehanna International Group, LLP | 41,941 | $387.1K |
| Squarepoint Ops LLC | 26,312 | $242.9K |
| Maven Securities LTD | 24,800 | $228.9K |
| Trexquant Investment LP | 23,387 | $215.9K |
| Jump Financial, LLC | 19,783 | $182.6K |
| Verition Fund Management LLC | 17,306 | $159.7K |
| HRT Financial LP | 15,257 | $140.0K |
| Engineers Gate Manager LP | 14,734 | $136.0K |
| Prudential Financial Inc | 12,070 | $111.4K |
| Invesco Ltd. | 11,312 | $104.4K |
| Credit Suisse AG | 10,607 | $97.9K |
| Cubist Systematic Strategies, LLC | 10,500 | $96.9K |
| Deutsche Bank AG | 4,965 | $45.8K |
Not filed for Q3 2023 yet (1)
Institutions that held IGM Biosciences, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Endurance Wealth Management, Inc. | 300 | $3.00K |